Bethesda, MD – The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): Hematologic Malignancies.
The 2013 FASEB conference on Hematologic Malignancies is an important and unique scientific conference where basic and translational research on leukemias, lymphomas, and myeloma is presented in detail in the premier meeting in the field. The underlying theme for the 2013 conference is “Genomics and Targeted Therapy”. This meeting includes outstanding researchers from around the world presenting cutting edge research directed towards genomic profiling of hematologic malignancies, mechanistic studies into hematopoietic transformation, and the development of novel, molecularly targeted therapies for patients with hematologic neoplasms.
FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC
Since 1982, FASEB SRC has offered a continuing series of inter-disciplinary exchanges that are recognized as a valuable complement to the highly successful society meetings. Divided into small groups, scientists from around the world meet intimately and without distractions to explore new approaches to those research areas undergoing rapid scientific changes.
In efforts to expand the SRC series, potential organizers are encouraged to contact SRC staff at SRC@faseb.org
. Proposal guidelines can be found at www.faseb.org/SRC
FASEB is composed of 26 societies with more than 100,000 members, making it the largest coalition of biomedical research associations in the United States. Our mission is to advance health and welfare by promoting progress and education in biological and biomedical sciences through service to our member societies and collaborative advocacy.